Literature DB >> 10463293

Detection of mycobacterial infections using the Dieterle stain.

J G Brady1, G E Schutze, R Seibert, H V Horn, B Marks, D M Parham.   

Abstract

Retrospective review comparing the modified Dieterle stain with standard acid-fast stains was performed on seven surgical pathology cases that contained culture-positive mycobacteria infections. Tissues examined comprised cervical and submandibular lymph nodes and soft tissues of the face and chest. Modified Dieterle staining was performed on paraffin-embedded tissue sections, and the results were compared with those of hematoxylineosin stains and auramine-rhodamines and carbolfuchsin acid-fast stains. The acid-fast stain showed organisms in three of seven cases on initial review and five of seven cases on retrospective review; the auramine-rhodamine stain retrospectively revealed organisms in five cases. In contrast, the Dieterle stain showed organisms in all seven sections on retrospective examination. Dieterle stains revealed either beaded bacilli or nocardia-like filamentous organisms, sometimes with abundant granular debris possibly representing degenerative organisms. In three cases in which bacteria were readily apparent with the Dieterle stain, only rare organisms could be identified with the acid-fast stain. The modified Dieterle stain was more sensitive than the acid-fast stain in the identification of mycobacteria in pediatric specimens, and its use is recommended in cases with necrotizing granulomas. However, its specificity is limited by morphologic similarities of the organisms to those of nocardiosis and cat scratch disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10463293     DOI: 10.1007/s100249900044

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  1 in total

Review 1.  Atypical mycobacterial lymphadenitis in childhood--a clinicopathological study of 17 cases.

Authors:  M J Evans; N M Smith; C M Thornton; G G Youngson; E S Gray
Journal:  J Clin Pathol       Date:  1998-12       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.